TC
ALLO icon

Trust Company’s Allogene Therapeutics ALLO Stock Holding History

Trust Company’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.2K Buy
+2,000
New +$3.81K ﹤0.01% 523

Other funds holding ALLO

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Trust Company's ALLO Position: Q3 2026 in Review

Trust Company opened a new position in Allogene Therapeutics (ALLO) in Q3 2026: 2,000 shares worth $3.2K. The stake represents ﹤0.01% of the portfolio and ranks #523 among its holdings.

3 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.

  • Trust Company held 2,000 shares of Allogene Therapeutics worth $3.2K as of Q3 2026.
  • Allogene Therapeutics was a new Trust Company position in Q3 2026.
  • Allogene Therapeutics made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #523 holding.
  • 3 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.